Prescription drug · ANDA
Metoprolol succinate NDC 71335-3167
Metoprolol succinate 100 mg/1 · Tablet, Extended release · Oral · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 71335-3167-1 | 71335316701 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-1)Marketed from Aug 4, 2026 | |
| 71335-3167-2 | 71335316702 | 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-2)Marketed from Aug 4, 2026 | |
| 71335-3167-3 | 71335316703 | 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-3)Marketed from Aug 4, 2026 | |
| 71335-3167-4 | 71335316704 | 20 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-4)Marketed from Aug 4, 2026 | |
| 71335-3167-5 | 71335316705 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-5)Marketed from Aug 4, 2026 | |
| 71335-3167-6 | 71335316706 | 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-6)Marketed from Aug 4, 2026 | |
| 71335-3167-7 | 71335316707 | 10 TABLET, EXTENDED RELEASE in 1 BOTTLE (71335-3167-7)Marketed from Aug 4, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Metoprolol succinate
- Generic name (nonproprietary)
- metoprolol succinate
- Active ingredients
- Metoprolol succinate — 100 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214110
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic beta-Antagonists (Mechanism)
- Identifiers
- Product ID 71335-3167_ccca9f4b-3d0f-467a-a4a7-8505fae57d0eSPL ID ccca9f4b-3d0f-467a-a4a7-8505fae57d0eSPL set ID a693bef9-cdfa-4012-ac87-873b9c5bf1cdRxCUI 866412UNII TH25PD4CCB
- Pharmacologic class
- beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N471335316701followed by a unit qualifier and the quantityPackage 71335-3167-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Metoprolol succinate, is a beta-adrenergic blocker indicated for the treatment of: Hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. ( 1.1 ) Angina Pectoris. ( 1.2 ) Heart Failure, to reduce the risk of cardiovascular mortality and heart failure hospitalizations in patients with heart failure ( 1.3 ) 1.1 Hypertension Metoprolol succinate extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These b…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214110
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Coupler LLC | 67046-1685 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Zhejiang Jutai Pharamceutical Co., Ltd | 71765-006 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Zhejiang Jutai Pharamceutical Co., Ltd | 71765-007 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Zhejiang Jutai Pharamceutical Co., Ltd | 71765-008 |
| Metoprolol succinate | Metoprolol succinate 25 mg/1 | Tablet, Extended releaseOral | Oryza pharmaceuticals Inc. | 72516-025 |
| Metoprolol succinate | Metoprolol succinate 50 mg/1 | Tablet, Extended releaseOral | Oryza pharmaceuticals Inc. | 72516-026 |
| Metoprolol succinate | Metoprolol succinate 100 mg/1 | Tablet, Extended releaseOral | Oryza pharmaceuticals Inc. | 72516-027 |
| Metoprolol succinate | Metoprolol succinate 200 mg/1 | Tablet, Extended releaseOral | Oryza pharmaceuticals Inc. | 72516-028 |